|Articles|January 1, 2020
- Pharmaceutical Executive-01-01-2020
- Volume 40
- Issue 1
Pharmaceutical Executive, January 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Pharm Exec’s 2020 Industry Outlookalmost 6 years ago
Sharing the Pricing Stage in 2020almost 6 years ago
Paving Bayer’s Future Pathalmost 6 years ago
Politics & Pricing to Shape Pharma Prospects in 2020almost 6 years ago
Pharma’s Brexit Routealmost 6 years ago
Is the Tail Wagging the Dog in Drug Market Entry?almost 6 years ago
A Happy New Year for European Pharma Policy?almost 6 years ago
Deeper Dive: Gene Therapy Manufacturingalmost 6 years ago
Country Report: ChinaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
